BackPulteGroup Overview

PulteGroup EBIT

Latest ebit for PHM: $2.1B, below the Healthcare sector average of $22B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$442.48M
221.62% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$2.09B
285.16% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

PulteGroup (PHM) FAQ

The latest EBIT for PHM is $2.1B as of June 2026. That compares with $540M in the prior-year period — up 285.2% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside PulteGroup's historical trend and sector peers before judging valuation or financial health.

Over the past year, PHM's EBIT moved from $540M to $2.1B — a 285.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PulteGroup's operating scale or balance-sheet position.

Against Healthcare companies, PHM currently prints $2.1B for EBIT, while the sector average sits near $22B. That is roughly 90.7% below the sector mean. Large gaps often invite a closer look at PulteGroup's growth, margins, and balance sheet.

A EBIT figure of $2.1B for PHM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting PHM's EBIT ($2.1B), review year-over-year change from $540M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.